<p>/PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY)（&#34;Waystar&#34;）是一家领先的医疗支付软件提供商，今天宣布由 EQT AB、Bain Capital, LP 和加拿大养老计划投资委员会（CPP Investments）及其各自的附属公司（统称为&#34;出售股东&#34;）承销的 2000 万股普通股的公开发行定价为每股 40.00 美元。此外，出售股东已向承销商授予了 30 天的选择权，以购买最多 300 万股额外的普通股。Waystar 不出售任何股份，也不会从出售股东的股份销售中获得任何收益。该发行预计将在 2025 年 2 月 24 日左右完成，具体取决于惯常的交割条件。</p>
<p>此次发行由摩根大通、高盛及巴克莱组成的承销团进行，他们担任联合主承销商，并作为此次发行的承销商代表。威廉·布莱尔、Evercore ISI、美银证券、RBC 资本市场、杰富瑞和德意志银行证券担任此次发行的联合账簿管理人。Canaccord Genuity 和雷蒙德·詹姆斯担任此次发行的共同管理人。</p>
<p>与这些证券相关的 S-1 表格注册声明，包括招股说明书，已向证券交易委员会提交并获得有效。此新闻稿不构成出售这些证券的要约或购买这些证券的邀请，也不应在任何州或司法管辖区内进行这些证券的销售，除非在该州或司法管辖区的证券法下注册或合格之前，该要约、邀请或销售是非法的。任何要约、邀请或购买要约，或任何证券的销售将根据 1933 年证券法的注册要求进行。</p>
<p>此次发行仅可通过招股说明书进行。初步招股说明书的副本可以通过以下方式获取：摩根大通证券公司，c/o Broadridge 金融解决方案，1155 Long Island Avenue, Edgewood, NY 11717，或通过电子邮件联系 [email protected]；高盛，注意：招股说明书部门，200 West Street, New York, NY 10282，电话（866）471-2526，或通过电子邮件联系 [email protected]；或巴克莱资本公司，c/o Broadridge 金融解决方案，1155 Long Island Avenue, Edgewood, NY 11717，电话（888）603-5847，或通过电子邮件联系 [email protected]。</p>
<p><strong>前瞻性声明</strong> 本新闻稿包含根据 1995 年《私人证券诉讼改革法》定义的前瞻性声明。前瞻性声明包括所有非历史事实的陈述。&#34;预期&#34;、&#34;假设&#34;、&#34;相信&#34;、&#34;继续&#34;、&#34;可能&#34;、&#34;估计&#34;、&#34;期望&#34;、&#34;打算&#34;、&#34;可能&#34;、&#34;计划&#34;、&#34;潜在&#34;、&#34;预测&#34;、&#34;项目&#34;、&#34;未来&#34;、&#34;将&#34;、&#34;寻求&#34;、&#34;可预见的&#34;、这些词的否定形式或类似术语和短语旨在识别前瞻性声明。本新闻稿中包含的前瞻性声明基于管理层当前的预期，并固有地受到各种风险、不确定性、假设或难以预测或量化的情况变化的影响。这些风险和不确定性包括但不限于与发行完成相关的风险和不确定性，以及在 Waystar 的 S-1 表格注册声明中描述的其他风险，该声明可能会不时修订，以及截至 2024 年 12 月 31 日的年度报告（Form 10-K）和任何后续向 SEC 提交的文件。除法律要求外，Waystar 没有义务更新任何前瞻性声明，以使这些声明符合实际结果或修订后的预期。</p>
<p><strong>关于 Waystar</strong> Waystar 的关键任务软件旨在简化医疗支付，以便提供者能够优先考虑患者护理并优化其财务表现。Waystar 服务于大约 30,000 个客户，代表超过 100 万名不同的提供者，包括美国新闻最佳医院荣誉榜上的 20 家机构中的 16 家。Waystar 的企业级平台每年处理超过 60 亿笔医疗支付交易，包括超过 1.8 万亿美元的年度总索赔，覆盖约 50% 的美国患者。Waystar 努力转变医疗支付，使提供者能够专注于最重要的事情：他们的患者和社区。</p>
<p><strong>媒体联系人</strong> Kristin Lee</p>
<p>[email protected]</p>
<p><strong>投资者联系人</strong> Sandy Draper</p>
<p>[email protected]</p>
<p>502-238-9511</p>
<p>来源 Waystar</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMjIwJk5ld3NJdGVtSWQ9TlkyNDMyOCZUcmFuc21pc3Npb25fSWQ9MjAyNTAyMjAyMzA1UFJfTkVXU19VU1BSX19fX19OWTI0MzI4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMjIwJk5ld3NJdGVtSWQ9TlkyNDMyOCZUcmFuc21pc3Npb25fSWQ9MjAyNTAyMjAyMzA1UFJfTkVXU19VU1BSX19fX19OWTI0MzI4"/></p>

<p>Waystar Holding Corp. 宣布以每股 40.00 美元的价格公开发行 2000 万股普通股，此次发行由 EQT AB、贝恩资本和 CPP Investments 的投资基金主导。预计该发行将在 2025 年 2 月 24 日左右完成，承销商包括摩根大通、高盛和巴克莱。Waystar 不会从此次销售中获得任何收益。已向美国证券交易委员会（SEC）提交了注册声明，发行将仅通过招股说明书进行</p>

<p>, /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY) (&#34;Waystar&#34;), a provider of leading healthcare payments software, today announced the pricing of its underwritten public offering of 20,000,000 shares of its common stock by certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment Board (CPP Investments), and their respective affiliates (collectively, the &#34;Selling Stockholders&#34;) at a price to the public of $40.00 per share. Additionally, the Selling Stockholders have granted the underwriters a 30-day option to purchase up to 3,000,000 additional shares of common stock. Waystar is not selling any shares and will not receive any proceeds from the sale of shares in the offering by the Selling Stockholders. The offering is expected to close on or about February 24, 2025, subject to customary closing conditions.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY)（&#34;Waystar&#34;）是一家领先的医疗支付软件提供商，今天宣布由 EQT AB、Bain Capital, LP 和加拿大养老计划投资委员会（CPP Investments）及其各自的附属公司（统称为&#34;出售股东&#34;）承销的 2000 万股普通股的公开发行定价为每股 40.00 美元。此外，出售股东已向承销商授予了 30 天的选择权，以购买最多 300 万股额外的普通股。Waystar 不出售任何股份，也不会从出售股东的股份销售中获得任何收益。该发行预计将在 2025 年 2 月 24 日左右完成，具体取决于惯常的交割条件。</p>
</div><p>The offering is being made through an underwriting group led by J.P. Morgan, Goldman Sachs &amp; Co. LLC, and Barclays, who are acting as joint lead book-running managers and as representatives of the underwriters for the offering. William Blair, Evercore ISI, BofA Securities, RBC Capital Markets, Jefferies and Deutsche Bank Securities are acting as joint bookrunners for the offering. Canaccord Genuity and Raymond James are acting as co-managers for the offering.</p>
<div class="lb-trans"><p>此次发行由摩根大通、高盛及巴克莱组成的承销团进行，他们担任联合主承销商，并作为此次发行的承销商代表。威廉·布莱尔、Evercore ISI、美银证券、RBC 资本市场、杰富瑞和德意志银行证券担任此次发行的联合账簿管理人。Canaccord Genuity 和雷蒙德·詹姆斯担任此次发行的共同管理人。</p>
</div><p>A registration statement on Form S-1, including a prospectus, relating to these securities has been filed with and declared effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.</p>
<div class="lb-trans"><p>与这些证券相关的 S-1 表格注册声明，包括招股说明书，已向证券交易委员会提交并获得有效。此新闻稿不构成出售这些证券的要约或购买这些证券的邀请，也不应在任何州或司法管辖区内进行这些证券的销售，除非在该州或司法管辖区的证券法下注册或合格之前，该要约、邀请或销售是非法的。任何要约、邀请或购买要约，或任何证券的销售将根据 1933 年证券法的注册要求进行。</p>
</div><p>The offering may be made only by means of a prospectus. Copies of the preliminary prospectus may be obtained by contacting: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email at [email protected]; Goldman Sachs &amp; Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at (866) 471-2526, or by email at [email protected]; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (888) 603-5847, or by email at [email protected].</p>
<div class="lb-trans"><p>此次发行仅可通过招股说明书进行。初步招股说明书的副本可以通过以下方式获取：摩根大通证券公司，c/o Broadridge 金融解决方案，1155 Long Island Avenue, Edgewood, NY 11717，或通过电子邮件联系 [email protected]；高盛，注意：招股说明书部门，200 West Street, New York, NY 10282，电话（866）471-2526，或通过电子邮件联系 [email protected]；或巴克莱资本公司，c/o Broadridge 金融解决方案，1155 Long Island Avenue, Edgewood, NY 11717，电话（888）603-5847，或通过电子邮件联系 [email protected]。</p>
</div><p><strong>Forward-Looking Statements</strong> This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. The words &#34;anticipate,&#34; &#34;assume,&#34; &#34;believe,&#34; &#34;continue,&#34; &#34;could,&#34; &#34;estimate,&#34; &#34;expect,&#34; &#34;intend,&#34; &#34;may,&#34; &#34;plan,&#34; &#34;potential,&#34; &#34;predict,&#34; &#34;project,&#34; &#34;future,&#34; &#34;will,&#34; &#34;seek,&#34; &#34;foreseeable,&#34; the negative version of these words, or similar terms and phrases are intended to identify forward-looking statements. The forward-looking statements contained in this press release are based on management's current expectations and are inherently subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. These risks and uncertainties include, but are not limited to, risks and uncertainties associated with the consummation of the offering and other risks described in Waystar's registration statement on Form S-1, as it may be amended from time to time, and its Annual Report on Form 10-K for the year ended December 31, 2024 and any subsequent filings with the SEC. Except as required by law, Waystar has no obligation to update any of these forward-looking statements to conform these statements to actual results or revised expectations.</p>
<div class="lb-trans"><p><strong>前瞻性声明</strong> 本新闻稿包含根据 1995 年《私人证券诉讼改革法》定义的前瞻性声明。前瞻性声明包括所有非历史事实的陈述。&#34;预期&#34;、&#34;假设&#34;、&#34;相信&#34;、&#34;继续&#34;、&#34;可能&#34;、&#34;估计&#34;、&#34;期望&#34;、&#34;打算&#34;、&#34;可能&#34;、&#34;计划&#34;、&#34;潜在&#34;、&#34;预测&#34;、&#34;项目&#34;、&#34;未来&#34;、&#34;将&#34;、&#34;寻求&#34;、&#34;可预见的&#34;、这些词的否定形式或类似术语和短语旨在识别前瞻性声明。本新闻稿中包含的前瞻性声明基于管理层当前的预期，并固有地受到各种风险、不确定性、假设或难以预测或量化的情况变化的影响。这些风险和不确定性包括但不限于与发行完成相关的风险和不确定性，以及在 Waystar 的 S-1 表格注册声明中描述的其他风险，该声明可能会不时修订，以及截至 2024 年 12 月 31 日的年度报告（Form 10-K）和任何后续向 SEC 提交的文件。除法律要求外，Waystar 没有义务更新任何前瞻性声明，以使这些声明符合实际结果或修订后的预期。</p>
</div><p><strong>About Waystar</strong> Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals Honor Roll. Waystar's enterprise-grade platform annually processes over 6 billion healthcare payment transactions, including over $1.8 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities.</p>
<div class="lb-trans"><p><strong>关于 Waystar</strong> Waystar 的关键任务软件旨在简化医疗支付，以便提供者能够优先考虑患者护理并优化其财务表现。Waystar 服务于大约 30,000 个客户，代表超过 100 万名不同的提供者，包括美国新闻最佳医院荣誉榜上的 20 家机构中的 16 家。Waystar 的企业级平台每年处理超过 60 亿笔医疗支付交易，包括超过 1.8 万亿美元的年度总索赔，覆盖约 50% 的美国患者。Waystar 努力转变医疗支付，使提供者能够专注于最重要的事情：他们的患者和社区。</p>
</div><p><strong>Media Contact</strong> Kristin Lee</p>
<div class="lb-trans"><p><strong>媒体联系人</strong> Kristin Lee</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p><strong>Investor Contact</strong> Sandy Draper</p>
<div class="lb-trans"><p><strong>投资者联系人</strong> Sandy Draper</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>502-238-9511</p>
<div class="lb-trans"><p>502-238-9511</p>
</div><p>SOURCE Waystar</p>
<div class="lb-trans"><p>来源 Waystar</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMjIwJk5ld3NJdGVtSWQ9TlkyNDMyOCZUcmFuc21pc3Npb25fSWQ9MjAyNTAyMjAyMzA1UFJfTkVXU19VU1BSX19fX19OWTI0MzI4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY24328&amp;Transmission_Id=202502202305PR_NEWS_USPR_____NY24328&amp;DateId=20250220"/></p>

Waystar 宣布普通股公开发行的定价